Cardiovascular safety of the cyclooxygenase-2 selective inhibitor parecoxib sodium: Review of pooled data from surgical studies: A-849
European Journal of Anaesthesiology（2006）
Abstract
1University of Western Australia, Perth, Australia; 2Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 3University of Texas Southwestern Medical Center at Dallas
MoreTranslated text
Key words
selective inhibitor parecoxib sodium,parecoxib sodium,cardiovascular safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined